Pentavalent vaccines are more expensive due to the lack of clarity around the demand.
Seek innovative approaches to reduce the cost of procuring pentavalent vaccine distributed in developing countries. We wan to reach more children while reducing the incidence of diptheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B.
Biological E. Limited
Private biotechnology company manufacturing pharmaceuticals and vaccines
Foundation focus: Reduce the cost of pentavalent vaccine
Volume Guaranty to Biological E Limited
Date: February 2012
Associated funding: None